The anti-proliferative inhibition of ellipticine in human breast mda-mb-231 cancer cells is through cell cycle arrest and apoptosis induction

Anti-Cancer Drugs

Volumn 16, Issue 7, 2005, Pages 789-795

  Kuo, Po Lin ^a   Hsu, Ya Ling ^a   Kuo, Yu Chun ^a   Chang, Cheng Hsiung ^b   Lin, Chun Ching ^a,b  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Bax Bcl 2; Bcl xL; Cell cycle; Ellipticine

Indexed keywords

CASPASE 3; CASPASE 9; CELL CYCLE PROTEIN; CELL CYCLE PROTEIN 2; CELL CYCLE PROTEIN 25; CYCLIN B1; CYTOCHROME C; DNA FRAGMENT; ELLIPTICINE; ENZYME INHIBITOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ELLIPTICINES; FEMALE; HUMANS; MITOCHONDRIA;

EID: 23344450582     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cad.0000171768.36317.93     Document Type: Article

References (15)

1. Goodwin S, Smith AF, Horning EC. Alkaloids of Ochrosia elliptica Labill. J Am Chem Soc 1959; 81:1903-1908.
2. Djuric Z, Everett CK, Valeriote FA. DNA damage and cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(diethylaminoethyl)-9- hydroxyellipticinium chloride. Cancer Res 1992; 52:1515-1519.
3. Monnot M, Mauffret O, Simon V, Lescot E, Psaume B, Saucier JM, et al. DNA-drug recognition and effects on topoisomerase II-mediated cytotoxicity. A three-mode binding model for ellipticine derivatives. J Biol Chem 1991; 266:1820-1829.
4. Shi LM, Myers TG, Fan Y, O'Connor PM, Paull KD, Friend SH, et al. Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity. Mol Pharmacol 1998; 53:241-251.
5. Devraj R, Barrett JF, Fernandez JA, Katzenellenbogen JA, Cushman M. Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates. J Med Chem 1996; 39:3367-3374.
6. 2-methylellipticinium acetate in human brain and non-brain tumor cell lines. Biochem Pharmacol 1995; 49:23-32.
7. Anderson WK, Gopalsamy A, Reddy PS. Design, synthesis, and study of 9-substituted ellipticine and 2-methylellipticinium analogues as potential CNS-selective antitumor agents. J Med Chem 1994; 37:1955-1963.
8. Kattan J, Durand M, Droz JP, Mahjoubi M, Marino JP, Azab M. Phase I study of retelliptine dihydrochloride (SR 95325 B) using a single two-hour intravenous infusion schedule. Am J Clin Oncol 1994; 17:242-245.
9. Hagg M, Berndtsson M, Mandic A, Zhou R, Shoshan MC, Linder S. Induction of endoplasmic reticulum stress by ellipticine plant alkaloids. Mol Cancer Ther 2004; 3:489-497.
10. Sancar A, Lindsey-Boltz LA, Unsal-Kaccmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and DNA damage checkpoints. Annu Rev Biochem 2004; 73:39-85.
11. 1 activation precedes nuclear mitotic events. Exp Cell Res 2000; 257:11-21.
12. Di Gennaro E, Barbarino M, Bruzzese F, De Lorenzo S, Caraglia M, Abbruzzese A, et al. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells. J Cell Physiol 2003; 195:139-150.
13. kip7 and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J Biol Chem 1997; 272:9424-9435.
14. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004; 432:307-315.
15. Jaattela M. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 2004; 23:2746-2756.